Your browser doesn't support javascript.
loading
Prevalence of Ile-460-Val/ParE substitution in clinical Streptococcus pneumoniae isolates that were less susceptible to fluoroquinolones.
Kawamura-Sato, Kumiko; Hasegawa, Tadao; Torii, Keizo; Ito, Hideo; Ohta, Michio.
Afiliação
  • Kawamura-Sato K; Department of Medical Technology, Nagoya University Graduate School of Health Science, 1-1-20, Daikominami, Nagoya, Aichi, 461-8673, Japan. kumiko@met.nagoya-u.ac.jp
Curr Microbiol ; 51(1): 27-30, 2005 Jul.
Article em En | MEDLINE | ID: mdl-15942701
ABSTRACT
A total of 73 clinical isolates of Streptococcus pneumoniae were measured for susceptibilities to nine fluoroquinolones, and nucleotide sequences of the quinolone resistance-determining regions (QRDRs) were determined. MIC90s of sparfloxacin, tosufloxacin, grepafloxacin, and gatifloxacin were less than 0.5 mg/L and the MIC90 of ciprofloxacin was 2 mg/L, although MIC values of some isolates to ciprofloxacin were more than 2 mg/L. We found that 60 of 73 isolates had only Ile-460-Val/ParE substitution and two isolates had an additional substitution of Ser-114-Gly/GyrA, while none of the isolates had any other substitutions in QRDRs of either ParC/E or GyrA/B. The isolates carrying Ile-460-Val/ParE substitution were more resistant to the fluoroquinolones norfloxacin and ciprofloxacin than the isolates with no amino acid substitution and the differences in MIC values were significant, suggesting that Ile-460-Val/ParE substitution in recent clinical S. pneumoniae isolates should be involved in the low-level fluoroquinolone resistance.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Streptococcus pneumoniae / Resistência Microbiana a Medicamentos / Fluoroquinolonas / DNA Topoisomerase IV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Microbiol Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Japão
Buscar no Google
Base de dados: MEDLINE Assunto principal: Streptococcus pneumoniae / Resistência Microbiana a Medicamentos / Fluoroquinolonas / DNA Topoisomerase IV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Microbiol Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Japão